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Balloon-Occluded Retrograde Transvenous 
Obliteration of a GastroRenal Shunt using 
Hydrogel-Coated Coil Embolization 
Daniel T. Ginat, M.D., M.S., Wael Saad M.D., and Takashi Kitanono, M.D. 
Balloon-retrograde transvenous obliteration (BRTO) can be an appropriate treatment modal-
ity for hepatic encephalopathy in the setting of portal-systemic shunting in selected patients. We 
describe a case of a large gastro-renal shunt that was successfully treated via combined BRTO and 
expandable hydrogel-coated coil embolization, with an emphasis on technique. 
Balloon-occluded retrograde transvenous oblitera-
tion (BRTO) is indicated for treatment for gastric va-
rices with gastro-renal shunts at some institutions [1-5]. 
The technique involves injecting gastric varices with 5% 
ethanolamine oleate iopamidol for 30 minutes via a bal-
loon catheter, while occluding the gastro-systemic shunt 
[1,2]. In certain conditions, such as in the presence of 
fundal gastric varices, standard BRTO is not effective. 
In addition, portal hypertensive changes, such as ascites 
and splenomegaly, can be aggravated shortly after BRTO 
in up to 82% of patients [6]. Instead, modified BRTO 
Introduction 
Case Report
A 60-year-old man with a history of end-stage liver 
disease secondary to hepatitis C, status post orthotopic 
liver transplant 15 years ago, presented with mental 
status changes attributed to hepatic encephalopathy. The 
encephalopathy was refractory to lactulose and rifaximin 
therapy.
techniques may be more appropriate. These include 
stepwise injection of the sclerosing agent, selective injec-
tion of the agent via a microcatheter, coil embolization 
of the afferent gastric veins, double-balloon catheteriza-
tion, and BRTO with percutaneous transhepatic portal 
venous access or transileocolic venous access [1,2,7]. 
Auxiliary procedures such as infusion of 50% glucose 
solution into collateral vessels can improve the outcome 
of BRTO [8]. Perhaps the most significant complica-
tion of BRTO is the development of esophageal varices 
[9,10].
In this report, we describe the technique for treat-
ment of gastric varices and gastro-splenic shunt in via 
BRTO in conjunction and expandable hydrogel coil 
embolization. 
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Interventional Procedure
Figure 1. 60-year-old man with hepatic encephalopathy. 
Axial CT demonstrates multiple gastric varices (arrow). 
A Seldinger’s needle was advanced into the right 
femoral vein and a 035 Rosen wire was inserted. An 
8 French sheath was then inserted over the wire. A 5 
French C2 catheter was inserted over the wire and the 
left renal vein was selected. A 035 glidewire was then 
advanced into the gastro-renal shunt. The catheter was 
advanced into the shunt and the wire was exchanged 
to a Rosen wire again. A 5 French balloon catheter was 
then advanced over the wire into the outflow vein of the 
shunt. A retrograde venogram was obtained while the 
outflow tract was occluded with the balloon (Fig. 2). 
The outflow vein was partially visualized. A microcath-
eter could not be advanced through the balloon catheter 
so a second puncture was made in the right groin. A 5 
French sheath was inserted using a similar technique. 
A 035 C2 catheter was advanced into the renal vein. 
A Renegade microcatheter was then advanced through 
the catheter past the balloon into the shunt using 014 
Transcend wire. The shunt was coiled using 6 Azure hy-
drogel detachable coils (Terumo, Somerset, N.J.). After 
approximately 15 minutes, complete occlusion of the 
shunt was observed (Fig. 3). There were no immediate 
Figure 2. 60-year-old man with hepatic encephalopathy. 
Digital subtraction angiogram shows a 5 French balloon 
catheter inflated within the outflow tract. 
Figure 3. 60-year-old man with hepatic encephalopathy. 
A subsequent digital subtraction angiogram demonstrates 
coils inserted proximal to the gastro-renal shunt outflow 
tract, providing complete occlusion. 
CT of the abdomen revealed an enlarged left renal 
vein and a complex of gastric varices, suggesting gastro-
renal shunting (Fig. 1). Consequently, percutaneous 
embolization of the shunt was requested. 
complications and the patient’s symptoms improved. 
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